IVERIC bio Inc.

(ISEE) Trade

By |

Profile

IVERIC bio Inc is a United States based gene therapy focused company developing treatments for patients with orphan inherited retinal diseases with unmet medical needs. Its gene therapy is a technology that seeks to correct a faulty gene by providing a healthy gene replacement, through a single treatment, resulting in the expression of a therapeutic protein that was otherwise not being produced.

Contact Information

Website: www.ivericbio.com
Email: kathy.galante@ophthotech.com
Main Phone: +1 212 845-8200
Address: One Penn Plaza
Address 2: 35th Floor, Suite 3520
State: NY
City / Town: New York
Country: USA
Postal Code: 10119

Issuer Information

Exchange: NGS
CEO: Glenn P. Sblendorio
Employees: 35
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

IVERIC bio Inc is a United States based gene therapy focused company developing treatments for patients with orphan inherited retinal diseases with unmet medical needs. Its gene therapy is a technology that seeks to correct a faulty gene by providing a healthy gene replacement, through a single treatment, resulting in the expression of a therapeutic protein that was otherwise not being produced.

Contact Information

Website: www.ivericbio.com
Email: kathy.galante@ophthotech.com
Main Phone: +1 212 845-8200
Address: One Penn Plaza
Address 2: 35th Floor, Suite 3520
State: NY
City / Town: New York
Country: USA
Postal Code: 10119

Issuer Information

Exchange: NGS
CEO: Glenn P. Sblendorio
Employees: 35
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.13 $ 0. (0.00%)
Last Price 1.13 Change $ 0. Change % 0.00 Tick N/A
Bid 1.16 Bid Size 100.00 Ask 1.26 Ask Size 2,500.00
Open N/A High N/A Low N/A Prev Close 1.13
Last Trade Volume 5,832 52 Wk Hi 2.61 52 Wk Low 1.02
Market Cap 46.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,477,420.00 EPS (TTM) 1.75 PE Ratio 0.60 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 12
Number of Buys 1 6
Number of Sells 1 6
Net Activity 11836 21944
Last 10 Buys Shares
Axel Bolte 1,000
Axel Bolte 1,000
Thomas Dyrberg 1,000
Nicholas G. Galakatos 1,000
Nicholas G. Galakatos 1,000
Axel Bolte 1,000
Last 10 Sell Shares
Glenn P. Sblendorio 1,000
David R. Guyer 1,000
Keith Westby 1,000
Keith Westby 1,000
David R. Guyer 1,000
David F Carroll 1,000
Glenn P. Sblendorio 1,000
David R. Guyer 1,000
Keith Westby 1,000
Barbara A. Wood 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4 4 4 4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/13/18 08/13/18 08/13/18 08/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 5 5 5 5